1
|
Urbanski G, Chabrun F, Lavigne C, Lacout C, Delattre E, Reynier P, Requin J. Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation. QJM 2024; 117:9-15. [PMID: 37758245 DOI: 10.1093/qjmed/hcad218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 09/15/2023] [Indexed: 10/03/2023] Open
Abstract
BACKGROUND Diagnosing iron deficiency is challenging in the presence of systemic inflammation. AIM To investigate the relationship between plasma C-reactive protein (CRP), serum ferritin (SF) and transferrin saturation (TS), with the objective of establishing a straightforward ratio applicable in the presence of inflammatory syndrome. DESIGN Test prospective cohort and validation retrospective cohort. METHODS A prospective cohort of inpatients (n = 140) assessed the correlation between CRP and SF/TS levels. The diagnostic performance of a determined ratio was evaluated for identifying iron deficiency (ID) using different definitions and in the presence of inflammation and/or chronic heart and/or kidney failure. A large validation cohort (n = 795) further assessed the predictive power of this ratio. RESULTS In a training cohort (median age 76 years [57-84]), a linear relation was observed between SF (µg/l) and CRP (mg/l), unlike with TS. The SF/CRP ratio accurately predicted ID, with receiver operating characteristic-area under the curve (ROC-AUC) values ranging from 0.85 to 0.92 for different ID definitions. A threshold of ≤6 demonstrated the highest Youden index (0.61). In the validation cohort (age 72 years [57-84]), the SF/CRP ratio exhibited an ROC-AUC of 0.88 [95% CI: 0.85-0.90], with an odds ratio of 37.9 [95% CI: 20.3-68.9] for the threshold of ≤6. CONCLUSION In this study, we demonstrated that the SF/CRP ratio, with a threshold of ≤6, is a simple and effective biomarker for ID, even in the presence of systemic inflammation or comorbidities. This ratio could potentially replace the complex set of criteria currently recommended by learned societies.
Collapse
Affiliation(s)
- G Urbanski
- Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA, USA
- Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
- MitoLab, Unité MITOVASC, UMR CNRS 6015, INSERM U1083, SFR ICAT, University of Angers, Angers, France
| | - F Chabrun
- MitoLab, Unité MITOVASC, UMR CNRS 6015, INSERM U1083, SFR ICAT, University of Angers, Angers, France
- Department of Biochemistry and Molecular Biology, University Hospital, Angers, France
| | - C Lavigne
- Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| | - C Lacout
- Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| | - E Delattre
- Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| | - P Reynier
- MitoLab, Unité MITOVASC, UMR CNRS 6015, INSERM U1083, SFR ICAT, University of Angers, Angers, France
- Department of Biochemistry and Molecular Biology, University Hospital, Angers, France
| | - J Requin
- Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| |
Collapse
|
2
|
Besse MC, Perrotin F, Aouba A, Gallou S, Karras A, Pillebout E, Urbanski G, Allain JS, Merlot C, Humbert S, Ramdani Y, Ferreira-Maldent N, Maillot F, Audemard-Verger A. Pregnancy outcome in patients with a medical history of immunoglobulin A vasculitis: a case-control study. Scand J Rheumatol 2024; 53:36-43. [PMID: 37439394 DOI: 10.1080/03009742.2023.2226518] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Accepted: 06/14/2023] [Indexed: 07/14/2023]
Abstract
OBJECTIVE Data on obstetric outcomes in patients with a history of immunoglobulin A vasculitis (IgA-V) are lacking. The aim of this study was to assess maternal, neonatal, and vasculitis outcomes during pregnancy. METHOD We conducted a French retrospective case-control study. Pregnancies of patients with a history of IgA-V (cases) were retrospectively studied and compared to pregnancies in women who developed IgA-V after their pregnancies and to pregnancies in healthy women (controls). RESULTS Twenty-six pregnancies in patients with a history of IgA-V were included and compared to 15 pregnancies in women who later developed IgA-V and 52 pregnancies in healthy women. Both gestational hypertension and pre-eclampsia were more frequent in the case group than in the other groups (23% vs 0% vs 0%, p < 0.01; 12% vs 7% vs 0%, p = 0.04). Hypertensive disorder of pregnancy occurred more frequently in patients with pre-existing kidney disease (78% vs 12%, p < 0.01). Caesarean section was more often performed in the case group than in the other groups (27% vs 0% vs 10%, p = 0.04). No foetal loss or maternal deaths occurred. There were no differences in delivery term or birth weight. No vasculitis flares were observed during pregnancy. CONCLUSION Women with a history of IgA-V appear to be at higher risk for gestational hypertension and pre-eclampsia, especially in cases with renal involvement; however, both mother and newborn outcomes appear to be favourable.
Collapse
Affiliation(s)
- M-C Besse
- Department of Internal Medicine and Clinical Immunology, CHU de Tours, Tours, France
- Tours University, Tours, France
| | - F Perrotin
- Tours University, Tours, France
- Department of Obstetrics and Gynecology, CHU de Tours, Tours, France
| | - A Aouba
- Department of Internal Medicine and Clinical Immunology, CHU de Caen, Caen, France
| | - S Gallou
- Department of Internal Medicine and Clinical Immunology, CHU de Caen, Caen, France
| | - A Karras
- Department of Nephrology, Hôpital Européen Georges Pompidou, Assistance publique des Hôpitaux de Paris, Paris, France
| | - E Pillebout
- Department of Nephrology, Hôpital Saint Louis, Assistance publique des Hôpitaux de Paris, Paris, France
| | - G Urbanski
- Department of Internal Medicine, CHU d'Angers, Angers, France
| | - J-S Allain
- Department of Internal Medicine, CH de Saint Malo, Saint Malo, France
| | - C Merlot
- Department of Internal Medicine, CHR Orléans, Orléans, France
| | - S Humbert
- Department of Internal Medicine, CHRU de Besancon, Besancon, France
| | - Y Ramdani
- Department of Internal Medicine and Clinical Immunology, CHU de Tours, Tours, France
- Tours University, Tours, France
| | - N Ferreira-Maldent
- Department of Internal Medicine and Clinical Immunology, CHU de Tours, Tours, France
| | - F Maillot
- Department of Internal Medicine and Clinical Immunology, CHU de Tours, Tours, France
- Tours University, Tours, France
| | - A Audemard-Verger
- Department of Internal Medicine and Clinical Immunology, CHU de Tours, Tours, France
- Tours University, Tours, France
| |
Collapse
|
3
|
Génin V, Agard C, De Boysson H, Rousselin C, Alexandra J, Martin M, SamsoN M, Sailler L, Urbanski G, Granel B, Espitia O. Impact pronostique de l’épaississement pariétal aortique associé ou non à l’hypermétabolisme pariétal dans l’aortite associée à l’artérite à cellules géantes. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Beaumesnil S, Urbanski G, Lavigne C, Lacombe V. Mastite associée aux IgG4. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Lacombe V, Patsouris A, Delattre E, Lavigne C, Lacout C, Urbanski G. Évolution de la vitamine B12 plasmatique au cours des cancers solides sous traitement curatif ou palliatif. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.10.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Hoefsloot S, Urbanski G, Lacout C, Bouvard B, Lavigne C. [Which adjuvant measures should be associated with long-term oral corticosteroid therapy in inflammatory diseases? A summary of existing French recommendations]. Rev Med Interne 2021; 42:616-624. [PMID: 34148673 DOI: 10.1016/j.revmed.2021.03.326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2020] [Revised: 03/01/2021] [Accepted: 03/21/2021] [Indexed: 11/28/2022]
Abstract
It is common to initiate a long-term corticosteroid therapy for inflammatory diseases. Various specialists are involved in this prescription, and associated measures to prevent side effects are not consensual, with the exception of osteoporosis. The specialty of the prescriber has indeed a significant impact on the attention paid to the adjuvant associated measures. The aim of this review was to draw a summary of the side effects of long-term corticosteroid therapy and of the existing recommendations related to associated measures to prevent them. Unfortunately, it is difficult to give clear recommendations because of the lack of evidence in some fields, especially as they should be adapted to patient's age and comorbidities. We propose a summary table of associated measures to long-term steroid therapy prescription and suggest a monitoring frequency.
Collapse
Affiliation(s)
- S Hoefsloot
- Service de rhumatologie, CHU Angers, 4, rue Larrey, Angers, France.
| | - G Urbanski
- Service de médecine interne-immunologie clinique, CHU Angers, 4, rue Larrey, Angers, France
| | - C Lacout
- Service de médecine interne-immunologie clinique, CHU Angers, 4, rue Larrey, Angers, France
| | - B Bouvard
- Service de rhumatologie, CHU Angers, 4, rue Larrey, Angers, France
| | - C Lavigne
- Service de médecine interne-immunologie clinique, CHU Angers, 4, rue Larrey, Angers, France
| |
Collapse
|
7
|
Beaumesnil S, Urbanski G, Gury A, Lacout C, Lavigne C, Lozac’h P. Érythème de Bazin : une manifestation rare de sarcoïdose. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Lacout C, Fouquet G, Terriou L, Millot G, Lavigne C, Orvain C, Dhôte R, Hamel J, Bloch-Queyrat C, Hermine O, Urbanski G. Risque infectieux de l’étoposide dans l’hémophagocytose lymphohistiocytaire de l’adulte. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Urbanski G, Terriou L, Fouquet G, Hamel J, Lavigne C, Orvain C, Larroche C, Hermine O, Bloch-Queyrat C, Lacout C. Facteurs associés à la mortalité à J30 dans l’hémophagocytose lymphohistiocytaire chez l’adulte : construction d’un score de mortalité à partir d’une cohorte multicentrique de 170 patients et validation sur une cohorte de 118 patients. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Lacombe V, Chabrun F, Lacout C, Ghali A, Capitain O, Patsouris A, Lavigne C, Urbanski G. L’élévation persistante de la vitamine B12 plasmatique comme marqueur prédictif de cancer solide. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Urbanski G, Assad S, Chabrun F, Chao De La Barca J, Blanchet O, Simard G, Gohier P, Lavigne C, Reynier P. Tear Metabogren : identification d’une signature métabolique lacrymale prédictive du syndrome de Sjögren primaire. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Espitia O, Blonz G, Magant J, Urbanski G, Landron C, Roblot P, Maillot F, Lavigne C, Hamidou M, Agard C. Aortites de l’artérite à cellules géantes symptomatiques vs asymptomatiques : évaluation des complications aortiques sur une cohorte multicentrique de 171 cas. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
13
|
Lacombe V, Lacout C, Lozac’h P, Ghali A, Gury A, Lavigne C, Urbanski G. Un nouveau seuil de débit salivaire pour le diagnostic de syndrome de Sjögren primaire. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Abisror N, Mariozo L, Esteve Valderde E, De Moreuil C, Billoir P, Pleguezuelo Garrote D, Carbillon L, Kayem G, Bornes M, Johanet C, Nicaise P, Urbanski G, Zigon P, Bezananary H, Mayer Pickel K, Benhamou Y, Fain O, Alijotas-Reig J, Mekinian A. SAPL séronégatif obstétrical : caractéristiques et prise en charge à partir d’une étude européenne. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
15
|
Murarasu A, Guettrot Imbert G, Le Guern V, Pasquier E, Yelnik C, Queyrel V, Schleinitz N, Ferreira-Maldent N, Langlois V, Urbanski G, Deneux-Tharaux C, Costedoat-Chalumeau N. Complications thrombotiques et hémorragiques au cours de la grossesse et du post-partum chez 119 patientes porteuses d’un syndrome des antiphospholipides et incluses dans le GR2. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Denis G, Sanhes L, Ziza J, Bauduer F, Berger M, Costello R, Mehdi K, Michaud M, Urbanski G, Rose C. Le challenge des splénomégalies inexpliquées : premières données de l’étude prospective multicentrique SMS (SplenoMegalyStudy). Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
17
|
Michaud M, Sené T, Lidove O, Chazerain P, Urbanski G, Chiche L, Bienvenu B, Alric L, Sailler L, Caudrelier L, Giraud J, Gaches F. Efficacité et Tolérance du Tocilizumab en utilisation hors AMM en médecine interne : étude rétrospective multicentrique. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Lacombe V, Lozac'h P, Orvain C, Lavigne C, Miot C, Pellier I, Urbanski G. [Treatment of ITP and AIHA in CVID: A systematic literature review]. Rev Med Interne 2019; 40:491-500. [PMID: 31101329 DOI: 10.1016/j.revmed.2019.02.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2018] [Revised: 02/11/2019] [Accepted: 02/24/2019] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Ten to 15% of common variable immunodeficiencies (CVID) develop auto-immune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Treatment is based on immunosuppressants, which produce blocking effects in the CVID. Our objective was to assess their risk-benefit ratio in these immunocompromised patients. METHODS We identified 17 articles detailing the treatment of AIHA and/or ITP in patients suffering from CVID through a systematic review of the MEDLINE database. RESULTS The increased infectious risk with corticosteroids does not call into question their place in the first line of treatment of ITP and AIHA in CVID. High-doses immunoglobulin therapy remain reserved for ITP with a high risk of bleeding. In second-line treatment, rituximab appears to be effective, with a lower infectious risk than the splenectomy. Immunosuppressants (azathioprine, methotrexate, mycophenolate, cyclophosphamide, vincristine, ciclosporine) are moderately effective and often lead to severe infections, meaning that their use is justified only in resistant cases and steroid-sparing. Dapsone, danazol and anti-D immunoglobulins have an unfavorable risk-benefit ratio. The place of TPO receptor agonists is still to be defined. The establishment of immunoglobulin replacement in the place of immunosuppressants (except for short-term corticotherapy) or splenectomy appears to be essential to limit the risk of infections, including in the absence of previous infections. CONCLUSION The presence of CVID does not mean that it is necessary to give up on corticosteroids as a first-line treatment and rituximab as a second-line treatment for AIHA and ITP, but it should be in addition to immunoglobulin replacement. A splenectomy should be reserved as a third-line treatment.
Collapse
Affiliation(s)
- V Lacombe
- Service de médecine interne et maladies vasculaires, CHU d'Angers, 4, rue Larrey, 49000 Angers, France
| | - P Lozac'h
- Service de médecine interne et maladies vasculaires, CHU d'Angers, 4, rue Larrey, 49000 Angers, France
| | - C Orvain
- Service des maladies du sang, CHU d'Angers, 4, rue Larrey, 49000 Angers, France
| | - C Lavigne
- Service de médecine interne et maladies vasculaires, CHU d'Angers, 4, rue Larrey, 49000 Angers, France; Centre de référence des déficits immunitaires primitifs CEREDIH, CHU d'Angers, site constitutif Angers, 4, rue Larrey, 49000 Angers, France
| | - C Miot
- Centre de référence des déficits immunitaires primitifs CEREDIH, CHU d'Angers, site constitutif Angers, 4, rue Larrey, 49000 Angers, France; Service d'immunologie-hématologie et oncologie pédiatriques, CHU d'Angers, 4, rue Larrey, 49000 Angers, France; Laboratoire d'immunologie et allergologie, CHU d'Angers, 4, rue Larrey, 49000 Angers, France
| | - I Pellier
- Centre de référence des déficits immunitaires primitifs CEREDIH, CHU d'Angers, site constitutif Angers, 4, rue Larrey, 49000 Angers, France; Service d'immunologie-hématologie et oncologie pédiatriques, CHU d'Angers, 4, rue Larrey, 49000 Angers, France
| | - G Urbanski
- Service de médecine interne et maladies vasculaires, CHU d'Angers, 4, rue Larrey, 49000 Angers, France; Centre de référence des déficits immunitaires primitifs CEREDIH, CHU d'Angers, site constitutif Angers, 4, rue Larrey, 49000 Angers, France.
| |
Collapse
|
19
|
Yvin E, Delaunay J, Lozac'h P, Lavigne C, Martin L, Urbanski G. [Chronic superficial urticaria associated with solid cancers: Case report and literature review]. Ann Dermatol Venereol 2019; 146:377-381. [PMID: 30905387 DOI: 10.1016/j.annder.2019.01.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 11/07/2018] [Accepted: 01/30/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Chronic urticaria is common and is generally idiopathic ("spontaneous"). Links between solid cancer and chronic urticaria have been mentioned in the literature. PATIENTS AND METHODS We report the case of a 63-year-old man presenting with superficial chronic urticaria associated with adenocarcinoma of the ethmoid sinus. We discuss the possibility of systemic origin in light of the severity of the disease and its resistance to treatment. Only recurrent ethmoidal cancer was highlighted. Curative care resulted in complete resolution of the urticaria without relapse at 32 months of follow-up. DISCUSSION In a literature review, we collected 17 cases of superficial chronic urticaria associated with cancer. These cases were marked by synchronous progression and by the inefficacy (86%) of anti-histamines and systemic corticosteroids. Although cases of chronic superficial urticaria associated with cancer remain rare, the condition merits discussion due to its severity and significant resistance to therapy.
Collapse
Affiliation(s)
- E Yvin
- Service de médecine interne et maladies vasculaires, CHU, 49000 Angers, France
| | - J Delaunay
- Service de dermatologie, CHU, 49000 Angers, France
| | - P Lozac'h
- Service de médecine interne et maladies vasculaires, CHU, 49000 Angers, France
| | - C Lavigne
- Service de médecine interne et maladies vasculaires, CHU, 49000 Angers, France
| | - L Martin
- Service de dermatologie, CHU, 49000 Angers, France
| | - G Urbanski
- Service de médecine interne et maladies vasculaires, CHU, 49000 Angers, France.
| |
Collapse
|
20
|
Lozac’h P, Le Meliner T, Michalak S, Ghali A, Lavigne C, Rousselet M, Urbanski G. Eruption papulonodulaire : un mode de révélation exceptionnel du lymphome du manteau. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
21
|
Lacombe V, Lozac’h P, Beucher A, Ghali A, Lavigne C, Urbanski G. Relation entre xérostomie subjective, objective et syndrome de Sjögren selon le sexe. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
de Saint-Martin G, Urbanski G, Beucher AB, Ebran JM. An ophthalmologic complication of Whipple's disease: Case report. J Fr Ophtalmol 2018; 41:e387-e389. [DOI: 10.1016/j.jfo.2017.11.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Revised: 10/23/2017] [Accepted: 11/16/2017] [Indexed: 10/28/2022]
|
23
|
Bach-Bunner M, Lacourreye L, Thouveny F, Lebigot J, Rouleau F, Boursier J, Urbanski G, Lavigne C. Étude rétrospective monocentrique de la prévalence de l’anémie et des facteurs associés à l’anémie dans une population de patients atteints de la maladie de Rendu-Osler. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Courdurié A, Urbanski G, Fuzibet J, Martis N, Queyrel V. Caractéristiques de la sclérodermie systémique à anti-PM-Scl : série rétrospective bicentrique. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
25
|
Lacombe V, Urbanski G, Brangier A, Annweiler C, Ghali A, Beucher A, Lavigne C. Chylothorax bilatéral et maladie de Waldenström. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Urbanski G, Villoteau A, Lozac’h P, N’guyen M, Schlumberger E, Beucher A, Ghali A, Simard G, Lavigne C. Carence en vitamine B12, metformine et inhibiteurs de pompe à protons. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
27
|
Bodez D, Guendouz S, Grateau G, Galat A, Avellino V, Kharoubi M, Guellich A, Urbanski G, Itti E, Deux J, Damy T, Georgin Lavialle S. Atteinte cardiaque au cours de l’amylose AA : étude prospective sur 38 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
28
|
Stankovic K, Georgin Lavialle S, Buob D, Poitou-Bernert C, Salle V, Urbanski G, Guichard J, Grosbois B, Christides C, Amselem S, Grateau G. L’obésité est-elle une cause émergente d’amylose AA ? À propos d’une cohorte française de 12 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Deshayes S, Georgin-Lavialle S, Hot A, Durel C, Hachulla E, Rouanes N, Audia S, Le Gallou T, Urbanski G, Bienvenu B, Aouba A, Grateau G. Traitement continu par anti-interleukine–1 dans le déficit en mévalonate kinase : étude rétrospective multicentrique française de 13 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Gury A, Delattre E, Rousselet-Chapeau M, Boyer F, Urbanski G, Lavigne C. Une maladie de Niemann-Pick type B révélée tardivement par une polyglobulie associée à une thrombopénie. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
31
|
Cabon M, Champtiaux N, Moulinet T, Meyer A, Campagne J, Lioger B, Urbanski G, Robbins A, Moulis G, Deligny C, Maurier F, Benveniste O. Myopathies nécrosantes à médiation immune à anticorps anti-SRP (ENDeMyoS) : série de 147 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
32
|
Audemard A, Baldolli A, Amoura Z, Cacoub P, Sanges S, Maurier F, Lioger B, Martis N, Riviere E, Urbanski G, Pillebout E, Terrier B. Description et pronostic des atteintes digestives au cours de la vascularite à IgA de l’adulte. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Yvin E, Urbanski G, Beucher A, Ghali A, Lavigne C. Hypothermies spontanées périodiques : à propos de deux cas familiaux. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
34
|
Lozac’h P, Urbanski G, Beauvillain C, Bouvard B, Rousselet M, Drouet M, Lavigne C. Pronostic des mastocytoses systémiques indolentes, suivi longitudinal de 36 patients dans le service de médecine interne d’un CHU. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Grimaux X, Sarre ME, Lozac’h P, Chevailler A, Roquelaure Y, Urbanski G, Martin L. Connectivite indifférenciée associée à l’exposition professionnelle au perchloréthylène. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
36
|
Yvin E, Lajoux B, Beucher A, Ghali A, Lavigne C, Urbanski G. Urticaire chronique d’origine paranéoplasique : à propos d’un cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
37
|
Audemard-Verger A, Dechartres A, Amoura Z, Le Gouellec N, Cacoub P, Urbanski G, Augusto J, Moulis G, Raffray L, Thervet E, Pillebout E, Terrier B. Caractéristiques et prise en charge des vascularites à IgA (purpura rhumatoïde) de l’adulte : résultats des 260 patients inclus dans l’enquête IGAVAS. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Yelnik CM, Urbanski G, Drumez E, Sobanski V, Maillard H, Lanteri A, Morell-Dubois S, Caron C, Dubucquoi S, Launay D, Duhamel A, Hachulla E, Hatron PY, Lambert M. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity. Lupus 2016; 26:163-169. [PMID: 27432808 DOI: 10.1177/0961203316657433] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Introduction The long-term risk of first thrombosis and benefit of prophylaxis in antiphospholipid antibody (aPL) carriers without history of thrombosis or obstetrical morbidity is poorly known. This study aimed to evaluate the long-term rate and risk factors associated with a first thrombosis in those patients. Patients and methods After a prior study ended in December 2005 and was already published, we extended the follow-up period of our cohort of aPL carriers. Results Ninety-eight of the 103 patients of the previous study were included. The annual first thrombosis rate was 2.3% per patient-year during a median of 13 years (6-17). None of the baseline characteristics was predictive of risk of first thrombosis, but persistent aPL over time were associated with an increased risk. The stronger association was found in triple aPL-positive carriers: OR 3.38 (95% CI: 1.24-9.22). Of note, conversely to our previous findings, no benefit of aspirin prophylaxis was observed. Conclusion The risk of first thrombosis in aPL carriers without history of thrombosis or obstetrical morbidity was significant, persisted linearly over time and was associated with persistent aPL. This risk was especially increased in triple aPL-positive carriers, in whom a close follow-up seems to be necessary. Nevertheless, the benefit of aspirin prophylaxis remained unclear.
Collapse
Affiliation(s)
- C M Yelnik
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - G Urbanski
- 2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - E Drumez
- 3 Département de biostatistiques, EA2694, Université Lille 2, CHRU Lille, France
| | - V Sobanski
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - H Maillard
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - A Lanteri
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - S Morell-Dubois
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - C Caron
- 4 Laboratoire d'Hémostase, Centre de Biologie-Pathologie-Génétique, CHRU Lille, France
| | - S Dubucquoi
- 1 Université Lille 2, UFR Médecine, Lille, France.,5 Institut d'Immunologie, Centre de Biologie-Pathologie-Génétique, CHRU Lille, France
| | - D Launay
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - A Duhamel
- 3 Département de biostatistiques, EA2694, Université Lille 2, CHRU Lille, France
| | - E Hachulla
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - P Y Hatron
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| | - M Lambert
- 1 Université Lille 2, UFR Médecine, Lille, France.,2 Service de Médecine Interne, Centre National de Référence des Maladies Systémiques Rares, Hôpital Claude Huriez, CHRU Lille, France
| |
Collapse
|
39
|
Chatelier É, Beucher A, Cousin M, Demiselle J, Lavigne C, Urbanski G. Entérite lupique : à propos de deux cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
40
|
Urbanski G, Schaepelynck B, Schlumberger E, Beucher A, Belizna C, Ghali A, Simard G, Lavigne C. Association entre la carence en vitamine B12, la sclérodermie systémique et le syndrome de Sjögren. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Urbanski G, Lavigne C, Renier G, Chevailler A. Description clinico-biologique d’une population rétrospective monocentrique de maladie de Biermer. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
42
|
Sanderink D, Senal N, Gardembas M, Belizna C, Urbanski G. Une cause rare d’entéropathie exsudative, la maladie de Waldmann : à propos d’un cas. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Bouquet E, Lavigne C, Urbanski G, Lainé-Cessac P. Les syndromes de Raynaud d’origine médicamenteuse : analyse des données de la base nationale de pharmacovigilance. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.273] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
44
|
Yelnik C, Urbanski G, Maillard H, Lanteri A, Chanson N, Stavris C, Morell-Dubois S, Launay D, Dubucquoi S, Hachulla E, Hatron P, Lambert M. Devenir en l’absence de traitement anticoagulant de 50 patients ayant un syndrome des antiphospholipides. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Yelnik C, Urbanski G, Lachatre M, Maillard H, Lanteri A, Chanson N, Stavris C, Launay D, Dubucquoi S, Hachulla E, Hatron P, Lambert M. Suivi prolongé d’une cohorte de 98 sujets porteurs d’anticorps antiphospholipides asymptomatiques. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Urbanski G, Yelnik C, Lachâtre M, Maillard H, Lanteri A, Chanson N, Stavris C, Launay D, Dubucquoi S, Hachulla E, Hatron P, Lambert M. Descriptions clinique et immunologique d’une population de syndromes des anti-phospholipides avec anticorps d’isotype M isolé au diagnostic. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Mahieu R, Urbanski G, Goumy L, Beucher A, Lavigne C. Une méningo-encéphalite chez un enfant de 7ans révélant une maladie de Takayasu. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Prundean A, Barth M, Urbanski G, Scherer C, Lavigne C, Bonneau D, Verny C. Sialidose de type 1 associant une atteinte neurologique, ophtalmologique et osseuse atypique. Rev Neurol (Paris) 2013. [DOI: 10.1016/j.neurol.2013.01.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
49
|
Urbanski G, Dib M, Simon A, Croué A, Arbeille B, Callewaert B, Vanakker O, Ifrah N, Martin L. Cutis laxa acquise associée à une gammapathie monoclonale chez un patient porteur d’une mutation du gène de l’élastine. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Urbanski G, Caillon A, Begorre M, Henrion D, Belizna C. Effet de l’hydroxychloroquine sur la vaso-réactivité dans un modèle murin C57BL/6 de syndrome des antiphospholipides. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|